Rizos H - Search Results

1

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma.

Diefenbach RJ, Lee JH, Rizos H. Diefenbach RJ, et al. Among authors: rizos h. Melanoma Manag. 2020 Jul 30;7(3):MMT46. doi: 10.2217/mmt-2020-0010. Melanoma Manag. 2020. PMID: 32922728 Free PMC article. No abstract available.

2

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.

Gray ES, Rizos H, Reid AL, Boyd SC, Pereira MR, Lo J, Tembe V, Freeman J, Lee JH, Scolyer RA, Siew K, Lomma C, Cooper A, Khattak MA, Meniawy TM, Long GV, Carlino MS, Millward M, Ziman M. Gray ES, et al. Among authors: rizos h. Oncotarget. 2015 Dec 8;6(39):42008-18. doi: 10.18632/oncotarget.5788. Oncotarget. 2015. PMID: 26524482 Free PMC article.

3

Oncolytic virotherapy using herpes simplex virus: how far have we come?

Sokolowski NA, Rizos H, Diefenbach RJ. Sokolowski NA, et al. Among authors: rizos h. Oncolytic Virother. 2015 Nov 25;4:207-19. doi: 10.2147/OV.S66086. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512683 Free PMC article. Review.

4

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma.

Lee JH, Long GV, Boyd S, Lo S, Menzies AM, Tembe V, Guminski A, Jakrot V, Scolyer RA, Mann GJ, Kefford RF, Carlino MS, Rizos H. Lee JH, et al. Among authors: rizos h. Ann Oncol. 2017 May 1;28(5):1130-1136. doi: 10.1093/annonc/mdx026. Ann Oncol. 2017. PMID: 28327969 Free article.

5

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients.

Lim SY, Lee JH, Welsh SJ, Ahn SB, Breen E, Khan A, Carlino MS, Menzies AM, Kefford RF, Scolyer RA, Long GV, Rizos H. Lim SY, et al. Among authors: rizos h. Biomark Res. 2017 Nov 10;5:32. doi: 10.1186/s40364-017-0112-9. eCollection 2017. Biomark Res. 2017. PMID: 29152306 Free PMC article.

6

Liquid biomarkers in melanoma: detection and discovery.

Lim SY, Lee JH, Diefenbach RJ, Kefford RF, Rizos H. Lim SY, et al. Among authors: rizos h. Mol Cancer. 2018 Jan 17;17(1):8. doi: 10.1186/s12943-018-0757-5. Mol Cancer. 2018. PMID: 29343260 Free PMC article. Review.

7

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies.

Lee JH, Long GV, Menzies AM, Lo S, Guminski A, Whitbourne K, Peranec M, Scolyer R, Kefford RF, Rizos H, Carlino MS. Lee JH, et al. Among authors: rizos h. JAMA Oncol. 2018 May 1;4(5):717-721. doi: 10.1001/jamaoncol.2017.5332. JAMA Oncol. 2018. PMID: 29423503 Free PMC article.

8

Oncogenic signaling in uveal melanoma.

Park JJ, Diefenbach RJ, Joshua AM, Kefford RF, Carlino MS, Rizos H. Park JJ, et al. Among authors: rizos h. Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672. doi: 10.1111/pcmr.12708. Epub 2018 May 23. Pigment Cell Melanoma Res. 2018. PMID: 29738114 Review.

9

Monitoring Melanoma Using Circulating Free DNA.

Diefenbach RJ, Lee JH, Rizos H. Diefenbach RJ, et al. Among authors: rizos h. Am J Clin Dermatol. 2019 Feb;20(1):1-12. doi: 10.1007/s40257-018-0398-x. Am J Clin Dermatol. 2019. PMID: 30374893 Review.

10

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy.

Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang JYH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H. Lim SY, et al. Among authors: rizos h. Clin Cancer Res. 2019 Mar 1;25(5):1557-1563. doi: 10.1158/1078-0432.CCR-18-2795. Epub 2018 Nov 8. Clin Cancer Res. 2019. PMID: 30409824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page